Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

3.80
Delayed Data
As of Feb 22
 +0.19 / +5.26%
Today’s Change
2.47
Today|||52-Week Range
14.17
+6.92%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close3.61
Today’s open3.70
Day’s range3.70 - 4.08
Volume663,085
Average volume (3 months)194,889
Market cap$39.8M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+11.54%
Earnings growth (this year)+19.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.69%
P/E ratioNM
Price/Sales8,984.64
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
CLBSCaladrius Bioscience...0.000.00%
APVOAptevo Therapeutics ...-0.21-9.95%
CSBRChampions Oncology I...-0.12-3.64%
APOPCellect Biotechnolog...-0.67-9.97%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$10.4K
Annual profit (last year)-$20.9M
Net profit margin-200,671.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Richard J. Daly
Chief Financial Officer
Jonathan B. Lloyd Jones
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs